INS and type 2 diabetes mellitus: As a considerable proportion of people with type 2 diabetes struggle to achieve the recommended glycemic targets with currently available therapies, including insulin therapy14, fully closed-loop systems offer a new approach to improve glycemic outcomes to reduce the risk of long-term complications.